Current Report Filing (8-k)
15 Juli 2016 - 5:35PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event
reported):
July 8, 2016
EVENT
CARDIO GROUP INC.
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
|
0-52518
|
|
20-8051714
|
(State
or other jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
739
Colony Palm Drive
Boynton
Beach, Florida
|
|
33436
|
(Address of
principal executive offices)
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
[ ]
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
[ ]
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
[ ]
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item 2.01 Completion of Acquisition
or Disposition of Assets.
On July 8, 2016, Event Cardio Group Inc., a Nevada corporation (the
“Company”), acquired all of the outstanding shares of Ambumed, Inc., a Maryland corporation
(“Ambumed”), pursuant to a Stock Purchase Agreement dated June 30, 2016 with Richard Oswik and Joseph Hashim
(together, the “Shareholders”) of Ambumed (the “Ambumed Stock Purchase Agreement”). The consideration
for the acquisition consisted of $1,200,000, of which $600,000 was paid at closing and $600,000 is payable on the first
anniversary of the closing, together with two million (2,000,000) restricted shares of the Company’s common stock, of
which 500,000 shares were deposited in escrow to satisfy the indemnification obligations of the Shareholders. The number of
shares issued to the Shareholders is subject to adjustment if the market price of the common stock for the ten trading days
preceding August 1, 2017 is less than $0.25 per share. In connection with the acquisition, as a result of which Ambumed
has become a wholly-owned subsidiary of the Company, the Company entered into an employment agreement with Joseph Hashim to
serve as Chief Operating Officer of Ambumed until July 31, 2020. Under the employment agreement Mr. Hashim is entitled to an
initial salary of $150,000 during the first year ofthe agreement, $200,000 for the second year and $250,000 thereafter, plus
a bonus of up to $100,000 commencing in the second year if certain specified performance target are achieved. The agreement
also grants Mr. Hashim 3,000,000 restricted shares of the Company’s common stock, subject to specified
vesting criteria, plus options to purchase on or before July 31, 2020 up to an additional 1,000,000 shares of the
Company’s common stock at an initial exercise price of $0.15 per share, subject to adjustment for certain anti-dilution
events, such as stock splits and upon the occurrence of fundamental transactions such as mergers and other business
combinations.
Ambumed provides electrocardiography
support services designed specifically for physicians, hospitals, scanning services and home health care agencies, including a
24-hour/day ECG monitoring center, under the name National Cardiac Monitoring Center.
Item 3.02 Unregistered Sales of
Equity Securities.
On July 8, 2016, the Company issued
1,000,000 shares of the Company’s common stock to each of Richard Oswik and Joseph Hashim as part of the consideration for
the acquisition of all of the outstanding shares of Ambumed. The shares were issued pursuant to the exemption from registration
provided by Section 4(a)(2) of the Securities Act. The Company did not pay any sales commissions or broker fees in connection
with the issuance of the shares. The certificates evidencing the shares were endorsed with a legend restricting their sale or
other disposition without compliance with the registration requirements of the Securities Act or an exemption therefrom.
Item 7.01 Regulation FD Disclosure.
On July 11, 2016, the Company issued a press
release announcing the acquisition of Ambumed. The press release is attached as Exhibit 99.1 to this report.
The information in Exhibit 99.1 shall not
be deemed as “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”),
or otherwise subject to the liability of such Section, nor shall it be deemed incorporated by reference in any filing by us under
the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing,
unless expressly incorporated by specific reference in such filing.
Item 9.01 Financial Statements and
Exhibits
.
|
(a)
|
Financial
statements. The Company will file an amendment to this report to include the financial
statements of Ambumed within 71 days after the date of this report as permitted
pursuant to paragraph (a)(1) (iv) of this Item 9.01.
|
|
(b)
|
Pro
forma financial information. The Company will file an amendment to this report to include
the pro forma financial information concerning the Company as a result of the acquisition
of Ambumed within 71 days after the date of this report as permitted pursuant to
paragraph (a)(1) (iv) of this Item 9.01.
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: July 14, 2016
|
EVENT
CARDIO GROUP INC.
|
|
|
|
|
|
|
By:
|
/s/ John
Bentivoglio
|
|
|
|
John
Bentivoglio
|
|
|
|
Chief Executive Officer
|
|
ECGI (PK) (USOTC:ECGI)
Historical Stock Chart
Von Jan 2025 bis Feb 2025
ECGI (PK) (USOTC:ECGI)
Historical Stock Chart
Von Feb 2024 bis Feb 2025
Echtzeit-Nachrichten über ECGI Holdings Inc (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Event Cardio Group Inc. News-Artikel